Santhosh Kumar J Urumarudappa

Dr. Santhosh Kumar J Urumarudappa

Chulalongkorn University, Bangkok, Krung Thep Maha Nakhon, Thailand

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2017 in Drug Safety
Verified
Journal Article
Closed access
PDF file
RSRamanujam Srirama
Ramanujam Srirama
SUSanthosh Kumar J Urumarudappa
Santhosh Kumar J Urumarudappa
SSSeethapathy Gopalakrishnan Saroja
Seethapathy Gopalakrishnan Saroja
SNSteven G. Newmaster
Steven G. Newmaster
SRS. Ragupathy
S. Ragupathy
GGGudasalamani Gudasalamani
Gudasalamani Gudasalamani

26 November 2014 in International journal of legal medicine
Verified
Journal Article
Closed access
PDF file
SSSeethapathy Gopalakrishnan Saroja
Seethapathy Gopalakrishnan Saroja
DGDoss Ganesh
Doss Ganesh
SUSanthosh Kumar J Urumarudappa
Santhosh Kumar J Urumarudappa
USUmapathy Senthilkumar
Umapathy Senthilkumar
SNSteven G Newmaster
Steven G Newmaster
GGGudasalamani Gudasalamani
Gudasalamani Gudasalamani

6 January 2016 in Current Science
Verified
Journal Article
Closed access
SSSeethapathy Gopalakrishnan Saroja
Seethapathy Gopalakrishnan Saroja
SUSanthosh Kumar J Urumarudappa
Santhosh Kumar J Urumarudappa
AHA. S. Hareesha
A. S. Hareesha

14 September 2016 in International journal of legal medicine
Verified
Journal Article
Closed access
PDF file
SUSanthosh Kumar J Urumarudappa
Santhosh Kumar J Urumarudappa
NGNavdeep Gogna
Navdeep Gogna
SNSteven G. Newmaster
Steven G. Newmaster
KVKrishna Venkatarangaiah
Krishna Venkatarangaiah
RSRagupathy Subramanyam
Ragupathy Subramanyam
URUma Shaanker Ramanan
Uma Shaanker Ramanan

12 July 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SSSeethapathy Gopalakrishnan Saroja
Seethapathy Gopalakrishnan Saroja
MTMargey Tadesse
Margey Tadesse
SUSanthosh Kumar J Urumarudappa
Santhosh Kumar J Urumarudappa
SGSrikanth V. Gunaga
Srikanth V. Gunaga
RVRamesh Vasudeva
Ramesh Vasudeva
HWHelle Wangensteen
Helle Wangensteen
Garcinia L. (Clusiaceae) fruits are a rich source of (−)-hydroxycitric acid, and this has gained considerable attention as an anti-obesity agent and a popular weight loss food supplement. In this study, we assessed adulteration of morphologically similar samples of Garcinia using DNA barcoding, and used NMR to quantify the content of (−)-hydroxycitric acid and (−)-hydroxycitric acid lactone in raw herbal drugs and Garcinia food supplements. DNA barcoding revealed that mostly G. gummi-gutta (previously known as G. cambogia) and G. indica were traded in Indian herbal markets, and there was no adulteration. The content of (−)-hydroxycitric acid and (−)-hydroxycitric acid lactone in the two species varied from 1.7% to 16.3%, and 3.5% to 20.7% respectively. Analysis of ten Garcinia food supplements revealed a large variation in the content of (−)-hydroxycitric acid, from 29 mg (4.6%) to 289 mg (50.6%) content per capsule or tablet. Only one product contained quantifiable amounts of (−)-hydroxycitric acid lactone. Furthermore the study demonstrates that DNA barcoding and NMR could be effectively used as a regulatory tool to authenticate Garcinia fruit rinds and food supplements.

26 October 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SUSanthosh Kumar J Urumarudappa
Santhosh Kumar J Urumarudappa
CTChayapol Tungphatthong
Chayapol Tungphatthong
PPPinidphon Prombutara
Pinidphon Prombutara
Suchada SukrongSuchada Sukrong
Suchada Sukrong
Traditional medicines are widely traded across the globe and have received considerable attention in the recent past, with expectations of heightened demand in the future. However, there are increasing global concerns over admixture, which can affect the quality, safety, and efficacy of herbal medicinal products. In this study, we aimed to use DNA metabarcoding to identify 39 Thai herbal products on the Thai National List of Essential Medicines (NLEM) and assess species composition and admixture. Among the products, 24 samples were in-house-prepared formulations, and 15 samples were registered formulations. In our study, DNA metabarcoding analysis using ITS2 and rbcL barcode regions were employed to identify herbal ingredients mentioned in the products. The nuclear region, ITS2, was able to identify herbal ingredients in the products at the genus- and family-levels in 55% and 63% of cases, respectively. The chloroplast gene, rbcL, enabled genus- and family-level identifications in 58% and 73% of cases, respectively. In addition, plant species were detected in larger numbers (Family identified, absolute %) in registered herbal products than in in-house-prepared formulations. The level of fidelity increases concerns about the reliability of the products. This study highlights that DNA metabarcoding is a useful analytical tool when combined with advanced chemical techniques for the identification of plant species in highly processed, multi-ingredient herbal products.